Ultragenyx Pharmaceutical Inc. (RARE) Earnings
NASDAQ·Healthcare·Biotechnology
$24.54
+2.29%
Mkt Cap $2.37B
Next Earnings
In 6 daysTue, May 5, 2026
EPS Estimate
-$1.53
9 analysts
Revenue Estimate
$159.32M
Last quarter: missed by -7.50% on EPS, +4.23% on revenue.
RARE reports 2026-05-05 earnings on Tuesday, May 5, 2026 (6 days from today). Consensus estimates are EPS -$1.53 and revenue $159.32M.
Last quarter, RARE missed EPS estimates by 7.5% on revenue of $207.00M.
View RARE earnings dates & historyEPS — Estimate vs Actual
Mkt Cap
$2.37B
P/E
—
Fwd P/E
—
P/S
3.52
Rev TTM
—
EPS TTM
-$5.84